What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Schizophrenia
- Psychiatry
Jeffrey A. Lieberman mainly investigates Schizophrenia, Psychiatry, Psychosis, Internal medicine and Antipsychotic.
Jeffrey A. Lieberman works in the field of Schizophrenia, focusing on Clozapine in particular.
His Psychiatry research focuses on Pediatrics and how it relates to Tardive dyskinesia.
His study in Psychosis is interdisciplinary in nature, drawing from both First episode, Brain morphometry, Neuroscience and Meta-analysis.
His Internal medicine research is multidisciplinary, incorporating elements of Clinical Global Impression, Endocrinology and Brief Psychiatric Rating Scale.
His Antipsychotic research also works with subjects such as
- Olanzapine together with Quetiapine, Anesthesia, Haloperidol and Dopamine antagonist,
- Risperidone together with Randomized controlled trial.
His most cited work include:
- Biological insights from 108 schizophrenia-associated genetic loci (4834 citations)
- Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia (4568 citations)
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (1570 citations)
What are the main themes of his work throughout his whole career to date?
Jeffrey A. Lieberman mainly focuses on Schizophrenia, Psychiatry, Internal medicine, Psychosis and Antipsychotic.
The Schizophrenia study combines topics in areas such as Genetics and Neuroscience.
His research investigates the connection between Psychiatry and topics such as Clinical psychology that intersect with problems in Neurocognitive.
His research in Internal medicine focuses on subjects like Endocrinology, which are connected to Neuroactive steroid.
Jeffrey A. Lieberman combines subjects such as First episode, Magnetic resonance imaging and Cognition with his study of Psychosis.
In his study, Risperidone, Haloperidol and Anesthesia is strongly linked to Olanzapine, which falls under the umbrella field of Antipsychotic.
He most often published in these fields:
- Schizophrenia (45.40%)
- Psychiatry (43.03%)
- Internal medicine (33.71%)
What were the highlights of his more recent work (between 2013-2021)?
- Schizophrenia (45.40%)
- Psychiatry (43.03%)
- Internal medicine (33.71%)
In recent papers he was focusing on the following fields of study:
His main research concerns Schizophrenia, Psychiatry, Internal medicine, Antipsychotic and Psychosis.
His biological study deals with issues like Pharmacology, which deal with fields such as Agonist.
Jeffrey A. Lieberman combines subjects such as Psychotherapist and Affect with his study of Psychiatry.
His studies deal with areas such as Placebo, Endocrinology, Oncology and Positive and Negative Syndrome Scale as well as Internal medicine.
Jeffrey A. Lieberman works mostly in the field of Antipsychotic, limiting it down to topics relating to Pharmacogenetics and, in certain cases, Allele, as a part of the same area of interest.
His work in Psychosis covers topics such as Intervention which are related to areas like Early detection.
Between 2013 and 2021, his most popular works were:
- Biological insights from 108 schizophrenia-associated genetic loci (4834 citations)
- Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores (575 citations)
- Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (518 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Schizophrenia
- Gene
His primary areas of study are Schizophrenia, Psychiatry, Antipsychotic, Internal medicine and Psychosis.
His Schizophrenia study incorporates themes from Genome-wide association study, Intervention, Magnetic resonance imaging and Functional magnetic resonance imaging, Neuroscience.
His study in the field of Cognition, Schizophrenia, Biological psychiatry and Schizotypy is also linked to topics like Suicidal ideation.
He interconnects Genetics, Clozapine, Bioinformatics, Meta-analysis and Pharmacology in the investigation of issues within Antipsychotic.
The Internal medicine study combines topics in areas such as Placebo, Linkage disequilibrium, Oncology and Positive and Negative Syndrome Scale.
His Psychosis study integrates concerns from other disciplines, such as Logistic regression, Pacific islanders, Affect and Clinical psychology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
